• Contact Us

  • News and Events

  • Pipeline
    NM002 NM001 NP339 for Invasive Fungal Disease NP339 for Respiratory Fungal Disease NP213 NP432

  • Technology

  • About Us
    Board and Management Investors Corporate Social Responsibility
       
  • Follow
  • Follow
  • Follow
  • About Us
    • Board and Management
    • Investors
    • Corporate Social Responsibility
  • Technology
  • Pipeline
    • NM002
    • NM001
    • NP339 for Invasive Fungal Disease
    • NP339 for Respiratory Fungal Disease
    • NP213
    • NP432
  • News and Events
  • Contact Us

NovaBiotics attending the BIO Digital Meeting, June 2021

by Paul McIntosh | May 21, 2021 | 2021, Events

  NovaBiotics are looking forward to participating at the upcoming BIO Digital Meeting taking place on June 10-11 & 14-18, 2021.  The team are ready to meet with all interested parties and explain how we are using immunology to deliver novel therapies for...
NovaBiotics Attending BIO CEO & Investor Digital Conference

NovaBiotics Attending BIO CEO & Investor Digital Conference

by Paul McIntosh | Feb 2, 2021 | 2021, Events

CEO Dr Deborah O’Neil and the NovaBiotics team will be attending the BIO CEO & Investor Conference, hosted by the Biotechnology Innovation Organization on the 16th-18th February 2021.  Meet with us through the event portal BIO CEO & Investor Event to...

Recent Posts

  • NovaBiotics to Present Preclinical Data on NP339 and Sponsor Symposium on New Antifungals at Upcoming 10th Congress on Trends in Medical Mycology
  • NovaBiotics publishes further data on the mechanism of action of its candidate NM001 therapy for cystic fibrosis (CF)
  • NovaBiotics Highlights Advantages of Novel Immune-Based Approach to Combatting Fungal and Bacterial Infectious Diseases at Peptide Therapeutics Forum 2021
  • NovaBiotics Announces Presentation at Upcoming Peptide Therapeutics Forum 2021
  • NovaBiotics Named as One of Scotland’s Top Ten Biotech Companies to Watch Out For

Recent Comments

    NovaBiotics Ltd
    Silverburn Crescent
    Bridge of Don
    Aberdeen
    AB23 8EW, UK

    Tel:+44 (0)1224 711377

    Registered Company
    No. SC272344

    NovaBiotics Inc
    One Boston Place,
    Suite 2600,
    Boston
    MA, 02108

    Tel:+1 866 259 4527

    NovaBiotics
    90 Upper George's Street,
    Dun Laoghaire,
    Co. Dublin,
    A96 R8R9

    Tel:+353 1 2712605

    Registered Company
    No. 642058

    News and Events

    About Us

    Therapeutic Focus

    Technology

    Pipeline

    Contact Us